OTCMKTS:ABCZY - ABCAM PLC/ADR Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $15.05 -0.04 (-0.27 %) (As of 03/24/2019 01:22 PM ET)Previous Close$15.05Today's Range$15.05 - $15.0552-Week Range$12.52 - $20.2875Volume464 shsAverage Volume872 shsMarket Capitalization$3.08 billionP/E RatioN/ADividend Yield0.50%Beta1.95 ProfileDiscussionChartDividendHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies; ELISA, matched antibody pairs and multiplex immunoassays; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex miRNA assays. Its products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. The company also sells its products online. Abcam plc was founded in 1998 and is based in Cambridge, the United Kingdom. Receive ABCZY News and Ratings via Email Sign-up to receive the latest news and ratings for ABCZY and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Industrial inorganic chemicals, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:ABCZY Previous SymbolNASDAQ:ABCZY CUSIPN/A CIKN/A WebN/A PhoneN/ADebt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees1,100 Outstanding Shares204,960,000Market Cap$3.08 billion Next Earnings DateN/A OptionableNot Optionable ABCAM PLC/ADR (OTCMKTS:ABCZY) Frequently Asked Questions What is ABCAM PLC/ADR's stock symbol? ABCAM PLC/ADR trades on the OTCMKTS under the ticker symbol "ABCZY." How often does ABCAM PLC/ADR pay dividends? What is the dividend yield for ABCAM PLC/ADR? ABCAM PLC/ADR announced a Semi-Annual dividend on Monday, March 4th. Stockholders of record on Friday, March 15th will be given a dividend of $0.038 per share on Friday, April 26th. The ex-dividend date of this dividend is Thursday, March 14th. View ABCAM PLC/ADR's Dividend History. Has ABCAM PLC/ADR been receiving favorable news coverage? Press coverage about ABCZY stock has been trending positive recently, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. ABCAM PLC/ADR earned a news impact score of 2.1 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. Who are some of ABCAM PLC/ADR's key competitors? Some companies that are related to ABCAM PLC/ADR include Aurora Cannabis (ACB), WellCare Health Plans (WCG), Quest Diagnostics (DGX), Seattle Genetics (SGEN), Sino Biopharmaceutical (SBMFF), Sonic Healthcare (SHL), Bausch Health Companies (BHC), DexCom (DXCM), IPSEN S A/S (IPSEY), EXACT Sciences (EXAS), DENTSPLY SIRONA (XRAY), Ionis Pharmaceuticals (IONS), Genmab A/S (GNMSF), Steris (STE) and Cochlear (COH). What other stocks do shareholders of ABCAM PLC/ADR own? Based on aggregate information from My MarketBeat watchlists, some companies that other ABCAM PLC/ADR investors own include Crispr Therapeutics (CRSP), SM Energy (SM), Cognizant Technology Solutions (CTSH), CEVA (CEVA), Genomic Health (GHDX), Keane Group (FRAC), Alliance Data Systems (ADS), Selecta Biosciences (SELB), CNX Resources (CNX) and Maxim Integrated Products (MXIM). Who are ABCAM PLC/ADR's key executives? ABCAM PLC/ADR's management team includes the folowing people: Mr. Alan Thomas Hirzel BS, MS, MBA, CEO & Exec. Director (Age 51)Dr. Jonathan Simon Milner, Co-Founder & Non-Exec. Deputy Chairman (Age 54)Mr. Gavin Hilary James Wood BA (Hons), ACA, CFO & Exec. Director (Age 49)James Staveley, VP of Investor RelationsMs. Suzanne E. Smith LLB (Hons), MBA, Chief Legal Officer & Company Sec. How do I buy shares of ABCAM PLC/ADR? Shares of ABCZY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is ABCAM PLC/ADR's stock price today? One share of ABCZY stock can currently be purchased for approximately $15.05. How big of a company is ABCAM PLC/ADR? ABCAM PLC/ADR has a market capitalization of $3.08 billion. ABCAM PLC/ADR employs 1,100 workers across the globe. MarketBeat Community Rating for ABCAM PLC/ADR (OTCMKTS ABCZY)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 70 (Vote Outperform)Underperform Votes: 96 (Vote Underperform)Total Votes: 166MarketBeat's community ratings are surveys of what our community members think about ABCAM PLC/ADR and other stocks. Vote "Outperform" if you believe ABCZY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABCZY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/24/2019 by MarketBeat.com StaffFeatured Article: Does the discount rate affect the economy?